Aveanna Healthcare Holdings, Inc. 8-K

What Happened

• On March 20, 2026, Aveanna Healthcare Holdings, Inc. announced (via Form 8‑K Item 7.01) that it made an investor financial presentation available to investors. The presentation is attached to the filing as Exhibit 99.1 (“Aveanna Investor Presentation - March 2026”) and is incorporated by reference. The filing is signed by Matthew Buckhalter, Chief Financial Officer.

Key Details

• Date of disclosure: March 20, 2026 (Form 8‑K, Item 7.01, Regulation FD Disclosure).
• Exhibit attached: 99.1 — “Aveanna Investor Presentation - March 2026.”
• Filing signed by: Matthew Buckhalter, Chief Financial Officer (Principal Financial Officer).
• The 8‑K does not report earnings, financial statements, executive changes, or other material amendments—its purpose is to make the presentation publicly available.

Why It Matters

• This filing informs investors that Aveanna has publicly posted a presentation that may include updated financial metrics, strategy, or outlook; because it was filed under Regulation FD, the company is ensuring broad public access to the information. Investors should review Exhibit 99.1 for any content relevant to revenue, guidance, or strategic plans; the 8‑K itself does not present new financial results or personnel changes.